不成比例性分析在药物监督中的演变作用
Michele Fusaroli1, Emanuel Raschi1, Elisabetta Poluzzi1
1Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Expert opinion on drug safety
|June 24, 2024
概括
不成比例性分析对于检测罕见的药物不良反应至关重要. 将这些方法与其他数据源整合并解决偏见可以提高药物监测和患者安全.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 数据分析 数据分析
背景情况:
- 在IMI PROTECT项目 (2009-2015) 建立了不成比例性分析的信号检测良好实践.
- 随后的独立研究产生了宝贵的见解,但缺乏无集成.
研究的目的:
- 审查和整合IMI PROTECT建议与不成比例分析中的当前知识和挑战.
- 探索不相称性分析在药物监测中的应用和局限性.
主要方法:
- 最先进的文献审查.
- 将现有建议与最近的发现相结合.
- 讨论关键方面:定义研究对象,方法,分组,掩盖,药物相互作用,重复性,预期性和风险测量.
主要成果:
- 不成比例性分析对于及时检测罕见的不良反应是无与伦比的.
- 最近的研究提供了关于信号特征,风险因素和患者观点的见解.
- 在透明的沟通和解决药监督偏见方面仍然存在挑战.
结论:
- 尽管存在怀疑,但不成比例性分析对于药物安全信号检测至关重要.
- 需要进一步的研究来整合发现,改善沟通,并解决全面证据合成的偏见.
相关概念视频
Pharmacovigilance
821
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
821
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Control Governance: Regulatory Bodies and Their Impact
150
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
150
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Nonlinear Pharmacokinetics: Overview
352
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
352


